CPEC(SH:600339)2016-10-28 16:00Financial Performance - Operating revenue increased by 24.68% to CNY 1,734,565,732.11 compared to the same period last year[6] - The company reported a net loss attributable to shareholders of CNY -425,302,941.09, compared to a loss of CNY -300,642,157.98 in the same period last year[6] - Total operating revenue for the first nine months of 2016 reached CNY 1,734,565,732.11, a 24.6% increase from CNY 1,391,237,828.02 in the same period last year[30] - The net loss attributable to shareholders for the first nine months of 2016 was CNY 425,302,941.09, compared to a loss of CNY 300,642,157.98 in the same period last year, reflecting a 41.5% increase in losses[32] - The total comprehensive loss for the first nine months of 2016 was CNY 474,425,784.93, compared to a loss of CNY 335,868,877.89 in the same period last year[32] Asset and Liability Changes - Total assets decreased by 20.49% to CNY 2,580,492,207.41 compared to the end of the previous year[6] - Total liabilities decreased from CNY 3,174,122,870.36 to CNY 2,983,665,141.74, a decrease of about 6.0%[26] - Current assets decreased from CNY 574,406,935.37 to CNY 417,219,251.13, a reduction of about 27.4%[25] - Non-current assets decreased from CNY 2,670,985,548.24 to CNY 2,163,272,956.28, reflecting a decline of approximately 19.0%[25] - The company’s total equity turned negative, dropping from CNY 71,269,613.25 to -CNY 403,172,934.33, indicating a significant loss in shareholder value[26] Cash Flow Analysis - Net cash flow from operating activities decreased by 26.77% to CNY 160,013,001.24 compared to the same period last year[6] - Cash inflow from operating activities for the year-to-date reached ¥1,585,495,584.78, an increase of 5.5% compared to ¥1,502,598,244.06 in the previous year[41] - Cash inflow from sales of goods and services was ¥1,567,927,670.14, up from ¥1,443,004,476.20, reflecting a growth of 8.7%[40] - Cash outflow for purchasing goods and services was ¥985,424,680.97, which is an increase of 17.2% compared to ¥840,336,352.59 last year[41] - The company reported a net cash increase of -¥150,711,607.62 for the period, contrasting with a net increase of ¥27,432,569.34 in the previous year[41] Shareholder Information - The number of shareholders reached 56,650 at the end of the reporting period[10] - Net profit attributable to shareholders of the parent company decreased to -425,302,941.09 RMB, a decline of 124,660,783.11 RMB compared to the same period last year[13] - Minority shareholders' losses decreased significantly, reflecting the impact of the company's restructuring and increased fixed asset impairment provisions[16] Operational Costs and Expenses - Total operating costs for the first nine months of 2016 were CNY 2,217,782,552.18, up 27.0% from CNY 1,745,329,976.15 year-on-year[30] - Management expenses increased by 70.79% year-on-year, mainly due to costs associated with the suspension of adipic acid production and losses from inventory material disposal[15] - Sales expenses for the first nine months of 2016 decreased to CNY 75,021,001.48 from CNY 103,597,242.97 in the previous year, a reduction of 27.7%[31] Asset Impairment and Restructuring - Asset impairment losses increased by 562.06% year-on-year, mainly due to increased fixed asset impairment provisions resulting from the company's restructuring[15] - The company reported a significant increase in asset impairment losses, totaling CNY 426,155,821.82 for the first nine months of 2016, compared to CNY 64,368,297.02 in the same period last year[31] - The company is actively progressing with a major asset restructuring plan, with significant milestones achieved by September 2016, including board approvals and regulatory submissions[18] Cash and Equivalents - Cash and cash equivalents decreased by 60.90% to CNY 105,672,012.33 compared to the beginning of the year[11] - The ending cash and cash equivalents balance was ¥100,952,012.33, down from ¥130,679,340.19 at the end of the previous year[42]